Next Article in Journal
The Effective Synthesis of N-(Arylalkyl)-1-R-4-hydroxy-2,2-dioxo-1H-2λ6,1-benzothiazine-3-carboxamides as Promising Analgesics of a New Chemical Class
Previous Article in Journal
The Role of Polydimethylsiloxane in the Molecular Structure of Silica Xerogels Intended for Drug Carriers
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Sci. Pharm.
Volume 83
Issue 3
10.3797/scipharm.1502-01
scipharm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Activation of HIV-1 with Nanoparticle-Packaged Small-Molecule Protein Phosphatase-1-Targeting Compound

by
Kahli A. SMITH
1,2,
Xionghao LIN
1,
Oleg BOLSHAKOV
3,
James GRIFFIN
4,
Xiaomei NIU
1,
Dmytro KOVALSKYY
5,6,
Andrey IVANOV
1,
Marina JEREBTSOVA
7,
Robert E. TAYLOR
2,
Emmanuel AKALA
3 and
Sergei NEKHAI
1,2,7,8,*
1
Center for Sickle Cell Disease, Howard University, Washington DC 20059, USA
2
Department of Pharmacology, Howard University, Washington DC 20059, USA
3
Department of Pharmaceutical Sciences, Howard University, Washington DC 20059, USA
4
College of Engineering, Howard University, Washington DC 20059, USA
5
Department of Biochemistry, School of Medicine, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr., San Antonio TX 78229, USA
6
Enamine LLC, Princeton Corporate Plaza, 7 Deer Park Drive, Ste. M-3 Monmouth Jct., NJ 08852, USA
7
Department of Microbiology, College of Medicine, Howard University, Washington DC 20059, USA
8
Department of Medicine, Howard University, Washington DC 20059, USA
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2015, 83(3), 535-548; https://doi.org/10.3797/scipharm.1502-01
Submission received: 4 February 2015 / Accepted: 22 June 2015 / Published: 22 June 2015
Versions Notes

Abstract

Complete eradication of HIV-1 infection is impeded by the existence of latent HIV-1 reservoirs in which the integrated HIV-1 provirus is transcriptionally inactive. Activation of HIV-1 transcription requires the viral Tat protein and host cell factors, including protein phosphatase-1 (PP1). We previously developed a library of small compounds that targeted PP1 and identified a compound, SMAPP1, which induced HIV-1 transcription. However, this compound has a limited bioavailability in vivo and may not be able to reach HIV-1-infected cells and induce HIV-1 transcription in patients. We packaged SMAPP1 in polymeric polyethylene glycol polymethyl methacrylate nanoparticles and analyzed its release and the effect on HIV-1 transcription in a cell culture. SMAPP1 was efficiently packaged in the nanoparticles and released during a 120-hr period. Treatment of the HIV-1-infected cells with the SMAPP1-loaded nanoparticles induced HIV-1 transcription. Thus, nanoparticles loaded with HIV-1-targeting compounds might be useful for future anti-HIV-1 therapeutics.
Keywords: HIV-1; Transcription; Latency; Nanoparticles; Small molecules; PP1; SMAPP1 HIV-1; Transcription; Latency; Nanoparticles; Small molecules; PP1; SMAPP1

Share and Cite

MDPI and ACS Style

SMITH, K.A.; LIN, X.; BOLSHAKOV, O.; GRIFFIN, J.; NIU, X.; KOVALSKYY, D.; IVANOV, A.; JEREBTSOVA, M.; TAYLOR, R.E.; AKALA, E.; et al. Activation of HIV-1 with Nanoparticle-Packaged Small-Molecule Protein Phosphatase-1-Targeting Compound. Sci. Pharm. 2015, 83, 535-548. https://doi.org/10.3797/scipharm.1502-01

AMA Style

SMITH KA, LIN X, BOLSHAKOV O, GRIFFIN J, NIU X, KOVALSKYY D, IVANOV A, JEREBTSOVA M, TAYLOR RE, AKALA E, et al. Activation of HIV-1 with Nanoparticle-Packaged Small-Molecule Protein Phosphatase-1-Targeting Compound. Scientia Pharmaceutica. 2015; 83(3):535-548. https://doi.org/10.3797/scipharm.1502-01

Chicago/Turabian Style

SMITH, Kahli A., Xionghao LIN, Oleg BOLSHAKOV, James GRIFFIN, Xiaomei NIU, Dmytro KOVALSKYY, Andrey IVANOV, Marina JEREBTSOVA, Robert E. TAYLOR, Emmanuel AKALA, and et al. 2015. "Activation of HIV-1 with Nanoparticle-Packaged Small-Molecule Protein Phosphatase-1-Targeting Compound" Scientia Pharmaceutica 83, no. 3: 535-548. https://doi.org/10.3797/scipharm.1502-01

APA Style

SMITH, K. A., LIN, X., BOLSHAKOV, O., GRIFFIN, J., NIU, X., KOVALSKYY, D., IVANOV, A., JEREBTSOVA, M., TAYLOR, R. E., AKALA, E., & NEKHAI, S. (2015). Activation of HIV-1 with Nanoparticle-Packaged Small-Molecule Protein Phosphatase-1-Targeting Compound. Scientia Pharmaceutica, 83(3), 535-548. https://doi.org/10.3797/scipharm.1502-01

Article Metrics

Back to TopTop